Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06430554

Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability

This observational study will explore the effects of PEEP and position on regional lung ventilation-perfusion mismatch by electrical impedance tomography (EIT) in moderate-to-severe ARDS patients with different lung recruitability.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Zhongda Hospital, Southeast University

Nanjing, Jiangsu, 210009, China

Location status: Recruiting

Location contact

Fengmei Guo, Ph.D

CONTACT

[email protected]

+8613813841261

About this study

Acute respiratory distress syndrome (ARDS) is characterized by impaired ventilation-perfusion matching, which not only indicates the severity of the condition but also contributes to ventilation-induced lung injury. Higher positive end-expiratory pressure (PEEP) and prone position could improve ventilation-perfusion mismatch by recruiting collapsed lungs and facilitating more homogeneous ventilation, but these benefits might depend on lung recruitability. The present study aims to elucidate the regional effect of PEEP(low and high) and body position(supine and prone) on the ventilation-perfusion matching. Also endeavors to establish correlations between alterations in ventilation-perfusion matching patterns and the inherent lung recruitability.

Participants will be deeply sedated and paralyzed, ventilated in volume-controlled with protective ventilation (tidal volume=6-8 mL/Kg of predicted body weight and respiratory rate set to obtain normal pH). Then the patients will be sequentially assigned to each of four conditions as follows:

Low PEEP, supine position; High PEEP, supine position; Low PEEP, prone position; High PEEP, prone position. High PEEP and low PEEP is defined as 15 cmH2O and 5 cmH2O (or airway opening pressure, either of which was higher) respectively. Each measurement (e.g., arterial blood gas analysis, respiratory parameters, hemodynamics, EIT measurements) will be performed at least 15 minutes after changing ventilator settings and at least 1 hour after changing body positions. The timing of turning patients from supine to prone position is determined by the clinical team.

To assess lung recruitability, a single-breath derecruitment maneuver will be performed by changing PEEP 15 to 5 cmH2O (or airway opening pressure, either of which was higher) in supine position. Patients with recruitment-inflation ratio over the median value are defined as high recruiters.

EIT data will be collected by standard device (Infinity C500, Drager, Germany) with a sample rate of 50 Hz. The EIT belt will be placed directly below the armpits, between the third and fifth intercostal spaces. This positioning of the EIT belt will be maintained consistently during both supine and prone positions. A bolus of 10 ml 5% NaCl will be injected during a respiratory pause (≥8 s) through the central venous catheter to assess lung ventilation and perfusion distributions. The primary endpoint is EIT-based ventilation-perfusion matching (V/Q match%).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age ≥18 years
  • Moderate-to-severe ARDS as per the 2023 ESICM definition
  • Undergoing invasive mechanical ventilation
  • Planned prone position based on the attending physicians' decisions
  • Signed informed consent

Exclusion criteria

  • age ≥85 years
  • Pregnancy
  • Severe hemodynamic instability (> 30% increase in vasopressors in the last 6 hours or norepinephrine > 0.5 µg/kg/min)
  • Clinically suspected elevated intracranial pressure (>18 mm Hg)
  • Bronchopleural fistula
  • Contraindication to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode belt placement)
  • Severe hypernatremia (>170mmol/L)
  • Re-admission of patients already enrolled in this study, or patients who are participating in other studies

Treatment and study plan

Primary outcomes

  1. Ventilation-perfusion matching (V/Q match%)

    Time frame: Through study completion (within 24 hours)

    corresponding to the pixels that are both ventilated and perfused divided by the total number of pixels ventilated and/or perfused

Secondary outcomes

  1. percentage of dead space

    Time frame: Through study completion (within 24 hours)

    corresponding to the ventilated but nonperfused pixels divided by the total number of pixels ventilated and/or perfused

  2. percentage of shunt

    Time frame: Through study completion (within 24 hours)

    corresponding to the perfused but nonventilated pixels divided by the total number of pixels ventilated and/or perfused

  3. Respiratory system compliance

    Time frame: Through study completion (within 24 hours)

    The compliance of respiratory system

  4. PaO2/FiO2 ratio

    Time frame: Through study completion (within 24 hours)

    PaO2/FiO2 ratio

Study contacts

Contact information is provided by the study sponsor or research team.

Fengmei Guo, PhD, MD

CONTACT

[email protected]

+8613813841261

Zhiqian Zha, MM

CONTACT

[email protected]

+8615505083904

Sponsors and collaborators

Lead sponsor

Zhongda Hospital

Other

Registry information

Official study title

Personalized Ventilatory Strategy Based on Ventilation-perfusion Mismatch and Lung Recruitability in Moderate-to-severe ARDS Patients

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
May 28, 2024
Registry last updated
Feb 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.